IL158250A0 - 3,7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds - Google Patents

3,7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds

Info

Publication number
IL158250A0
IL158250A0 IL15825002A IL15825002A IL158250A0 IL 158250 A0 IL158250 A0 IL 158250A0 IL 15825002 A IL15825002 A IL 15825002A IL 15825002 A IL15825002 A IL 15825002A IL 158250 A0 IL158250 A0 IL 158250A0
Authority
IL
Israel
Prior art keywords
diazabicyclo
formulations
antiarrhythmic compounds
antiarrhythmic
compounds
Prior art date
Application number
IL15825002A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL158250A0 publication Critical patent/IL158250A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL15825002A 2001-04-12 2002-04-12 3,7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds IL158250A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101327A SE0101327D0 (sv) 2001-04-12 2001-04-12 New crystalline forms
PCT/SE2002/000725 WO2002083688A1 (en) 2001-04-12 2002-04-12 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds

Publications (1)

Publication Number Publication Date
IL158250A0 true IL158250A0 (en) 2004-05-12

Family

ID=20283783

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15825002A IL158250A0 (en) 2001-04-12 2002-04-12 3,7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds

Country Status (29)

Country Link
US (1) US7217708B2 (cs)
EP (2) EP1550663A1 (cs)
JP (1) JP2004525970A (cs)
KR (1) KR20030087078A (cs)
CN (1) CN1269823C (cs)
AR (1) AR035452A1 (cs)
AT (1) ATE323095T1 (cs)
BR (1) BR0208829A (cs)
CA (1) CA2443470A1 (cs)
CZ (1) CZ20032760A3 (cs)
DE (1) DE60210598T2 (cs)
DK (1) DK1389213T3 (cs)
EE (1) EE200300504A (cs)
ES (1) ES2261721T3 (cs)
HU (1) HUP0303487A3 (cs)
IL (1) IL158250A0 (cs)
IS (1) IS6980A (cs)
MX (1) MXPA03009206A (cs)
NO (1) NO20034527L (cs)
NZ (1) NZ528560A (cs)
PL (1) PL367179A1 (cs)
PT (1) PT1389213E (cs)
RU (1) RU2286993C2 (cs)
SE (1) SE0101327D0 (cs)
SK (1) SK12572003A3 (cs)
TW (1) TWI237025B (cs)
UA (1) UA74629C2 (cs)
WO (1) WO2002083688A1 (cs)
ZA (1) ZA200307759B (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI259836B (en) * 2001-04-12 2006-08-11 Astrazeneca Ab Modified release formulation suitable for antiarrhythmic compounds
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401539D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
KR20080021114A (ko) * 2005-06-13 2008-03-06 아스트라제네카 아베 심부정맥의 치료를 위한 신규한 옥사비스피딘 화합물
AR053901A1 (es) * 2005-06-20 2007-05-23 Astrazeneca Ab Formas fisicas de oxabispidinas n,n'- disustituidas
JP2009501702A (ja) * 2005-06-20 2009-01-22 アストラゼネカ アクチボラグ N,n‘−二置換オキサビスピジン類の製造プロセス
TW200734342A (en) * 2005-12-15 2007-09-16 Astrazeneca Ab New compounds for the treatment of cardiac arrhythmias
US20070219223A1 (en) * 2006-03-07 2007-09-20 Endacea, Inc. Compositions and methods for treating respiratory disorders
AU2007265460B2 (en) 2006-06-26 2011-03-03 Akebia Therapeutics Inc. Prolyl hydroxylase inhibitors and methods of use
KR101652606B1 (ko) 2011-06-06 2016-08-30 아케비아 테라퓨틱스 인코포레이티드 암 치료 방법으로서 저산소증 유도 인자-2 알파를 안정화시키기 위한 화합물 및 조성물
NO2686520T3 (cs) 2011-06-06 2018-03-17
SG11201509998WA (en) 2013-06-13 2016-01-28 Akebia Therapeutics Inc Compositions and methods for treating anemia
US9701636B2 (en) 2013-11-15 2017-07-11 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
HK1247201A1 (zh) 2015-01-23 2018-09-21 阿克比治疗有限公司 2-(5-(3-氟苯基)-3-羟基吡啶甲醯胺)乙酸的固体形式、其组合物及用途
CR20170450A (es) 2015-04-01 2018-04-03 Akebia Therapeutics Inc Composiciones y métodos para el tratamiento de la anemia
MX2020011845A (es) 2018-05-09 2021-01-15 Akebia Therapeutics Inc Proceso para preparar acido 2-[[5-(3-clorofenil)-3-hidroxipiridina -2-carbonil]amino]acetico.
EP3947370A4 (en) 2019-03-28 2022-12-28 1st Biotherapeutics, Inc. Pharmaceutical salts of benzothiazol compounds, polymorphs and methods for preparation thereof
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
SE9902268D0 (sv) 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds

Also Published As

Publication number Publication date
RU2286993C2 (ru) 2006-11-10
EP1389213B1 (en) 2006-04-12
IS6980A (is) 2003-10-08
RU2003129231A (ru) 2005-04-10
WO2002083688A1 (en) 2002-10-24
EE200300504A (et) 2003-12-15
NO20034527L (no) 2003-12-10
ATE323095T1 (de) 2006-04-15
UA74629C2 (en) 2006-01-16
ES2261721T3 (es) 2006-11-16
CZ20032760A3 (cs) 2004-01-14
AR035452A1 (es) 2004-05-26
CA2443470A1 (en) 2002-10-24
PL367179A1 (en) 2005-02-21
MXPA03009206A (es) 2004-01-29
JP2004525970A (ja) 2004-08-26
HK1061026A1 (en) 2004-09-03
BR0208829A (pt) 2004-03-09
SK12572003A3 (sk) 2004-07-07
DE60210598D1 (de) 2006-05-24
DE60210598T2 (de) 2007-02-08
PT1389213E (pt) 2006-07-31
CN1514837A (zh) 2004-07-21
NO20034527D0 (no) 2003-10-09
US20040143000A1 (en) 2004-07-22
DK1389213T3 (da) 2006-07-10
CN1269823C (zh) 2006-08-16
KR20030087078A (ko) 2003-11-12
EP1550663A1 (en) 2005-07-06
ZA200307759B (en) 2005-01-03
HUP0303487A2 (hu) 2004-01-28
EP1389213A1 (en) 2004-02-18
SE0101327D0 (sv) 2001-04-12
NZ528560A (en) 2005-05-27
US7217708B2 (en) 2007-05-15
HUP0303487A3 (en) 2005-04-28
TWI237025B (en) 2005-08-01

Similar Documents

Publication Publication Date Title
AP2002002695A0 (en) Pyrrolo Ä2,3-dÜpyrimidine compounds
IL160708A0 (en) 1, 6-naphthyridine derivatives as antidiabetics
MXPA03007093A (es) Nueva composicion.
AU4787301A (en) 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
IL158250A0 (en) 3,7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds
ZA200005134B (en) Solid, quick dissolving cetirizine formulations.
MXPA03009698A (es) Vacuna multivalente que comprende un antigeno vih y un antigeno vsh y/o un antigeno vph.
ZA200110021B (en) Substituted imidazothiazoles as antidepressant agents.
ZA200206779B (en) Solid formulation.
ZA200207341B (en) Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7a]indole compounds.
EG23378A (en) Composition.
IL158033A0 (en) 3, 7-diazabicyclo [3.3.1] formulations as anti-arrhythmic compounds
IL158035A0 (en) 3, 7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds
IL162310A0 (en) 3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives
MXPA03008077A (es) Composicion humedecedora para la piel..
AU2002331972A1 (en) 3,4-methylenedioxy-substituted chalcones as therapeutic agents
MXPA03005965A (es) Composicion farmaceutica que contiene citalopram.
ZA200109571B (en) Novel compounds, their use and preparation.
SI1389213T1 (sl) 3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine
PL370505A1 (en) Substituted 1,5-diaminopentan-3-ol compounds
PL368536A1 (en) Novel 2,4-diaminothiazole derivatives
HK1062681A (en) 3,7-diazybicyclo 3.3.1] formulations as antiarrhytmic compounds
MXPA03006632A (es) Composicion solida.
EG23305A (en) Preparation of 1,2-dicloroethane.
PL371851A1 (en) 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives